Today's Low
₹ 1,260.00
Today's High
₹ 1,280.00
52 Weeks Low
₹ 334.65
52 Weeks High
₹ 907.70
Lower
₹ 999.25
Upper
₹ 1,498.85
Cigniti Technologies Limited provides software testing services worldwide. The company offers digital assurance services, such as artificial intelligence, Internet of Things, blockchain, big data and analytics, and mobile testing services, as well as digital assurance and testing, robotic process automation, cloud migration assurance, and 5G assurance services. It also provides quality engineering services, including DevOps testing, compatibility testing, functional testing, performance testing, security testing, regression testing, test automation, and crowdsourced testing. In addition, the company offers enterprise application assurance services comprising medical device testing, ERP testing, and salesforce testing; and test management services, such as agile testing, service virtualization, and test data management; and test advisory and transformation services. It serves the airlines, banking, communications, energy and utilities, financial services, healthcare and life sciences, insurance, logistics, manufacturing, media and entertainment, retail and ecommerce, and travel and hospitality industries. The company was formerly known as Chakkilam Infotech Limited. Cigniti Technologies Limited was incorporated in 1998 and is headquartered in Hyderabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 677.5 | 556.4 | 428.5 | 369.3 | 234.8 | 171.4 | 154.0 | 281.2 | 241.6 | 87.3 | 52.1 | 34.6 |
Total Non-Current Assets | 162.6 | 135.6 | 98.3 | 110.6 | 72.7 | 66.7 | 68.9 | 334.5 | 142.2 | 97.4 | 46.4 | 33.6 |
Total Assets | 840.1 | 691.9 | 526.8 | 479.9 | 307.5 | 238.1 | 222.9 | 635.9 | 384.1 | 184.9 | 98.8 | 68.1 |
Total Current Liabilities | 215.6 | 196.9 | 126.9 | 174.1 | 149.3 | 209.9 | 243.1 | 274.1 | 109.6 | 70.5 | 41.5 | 24.8 |
Total Non-Current Liabilities | 35.1 | 35.2 | 27.5 | 38.5 | 7.5 | 21.3 | 20.6 | 2.2 | 5.4 | 2.0 | 1.5 | 5.3 |
Shareholder's Funds | 589.4 | 459.8 | 372.4 | 267.2 | 150.7 | 6.9 | -40.8 | 359.6 | 269.1 | 112.4 | 55.9 | 38.1 |
Total Liabilities | 840.1 | 691.9 | 526.8 | 479.9 | 307.5 | 238.1 | 222.9 | 635.9 | 384.1 | 184.9 | 98.8 | 68.1 |
The Industry Price to BV stands at 10.10, vs the Price to BV of 4.79, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.04, vs the Debt to Equity Ratio of 0.32, which results in a Negative aspect.
The Industry Current Ratio stands at 2.65, vs the Current Ratio of 2.12, which results in a Negative aspect.
The Industry Quick Ratio stands at 2.65, vs the Quick Ratio of 2.12, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 1,647.6 | 1,241.8 | 896.5 | 872.0 | 816.1 | 693.3 | 619.3 | 594.8 | 378.9 | 259.1 | 150.9 | 33.8 |
Total Expenditure | 1,409.9 | 1,113.3 | 751.3 | 744.1 | 683.3 | 641.6 | 646.4 | 497.2 | 341.2 | 223.5 | 142.1 | 30.7 |
Operating Profit(Excl OI) | 252.4 | 142.7 | 158.9 | 150.3 | 160.0 | 52.6 | -21.8 | 101.4 | 39.3 | 36.5 | 8.8 | 3.1 |
Other Income | 14.7 | 14.2 | 13.7 | 22.5 | 27.3 | 0.9 | 5.3 | 3.7 | 1.6 | 0.9 | 0.0 | 0.1 |
Operating Profit | 252.4 | 142.7 | 158.9 | 150.3 | 160.0 | 52.6 | -21.8 | 101.4 | 39.3 | 36.5 | 8.8 | 3.1 |
Less: Interest | 4.4 | 5.1 | 5.6 | 8.0 | 14.6 | 17.0 | 16.1 | 6.0 | 2.9 | 1.2 | 0.3 | 0.3 |
PBDT | 248.0 | 137.7 | 153.3 | 142.3 | 145.4 | 35.7 | -37.9 | 95.3 | 36.3 | 35.3 | 8.5 | 2.8 |
Less: Depreciation Amortization | 26.4 | 16.2 | 12.3 | 11.5 | 3.2 | 2.7 | 17.0 | 11.3 | 5.4 | 2.4 | 1.6 | 1.0 |
PBT & Exceptional Items | 221.6 | 121.5 | 141.1 | 130.8 | 142.2 | 32.9 | -54.9 | 84.0 | 30.9 | 32.9 | 6.9 | 1.8 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -332.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 221.6 | 121.5 | 141.1 | 130.8 | 142.2 | 32.9 | -387.0 | 84.0 | 30.9 | 32.9 | 6.9 | 1.8 |
Less: Taxation | 53.3 | 29.8 | 35.7 | 9.2 | -5.1 | 0.8 | 7.9 | 34.4 | 5.5 | 7.3 | 1.9 | 0.6 |
Profit After Tax | 168.3 | 91.7 | 105.4 | 121.6 | 147.4 | 32.2 | -394.8 | 49.7 | 25.4 | 25.5 | 5.0 | 1.2 |
Earnings Per Share | 0.6 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | -1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Growth stands at 15.31, vs the PAT Growth of -17.48, which results in a Negative aspect.
The Industry PAT Margin stands at 17.02, vs the PAT Margin of 13.95, which results in a Negative aspect.
The Industry Dividend Yield stands at 2.32, vs the Dividend Yield of 0.44, which results in a Negative aspect.
The Industry PE Ratio stands at 34.79, vs the PE Ratio of 18.28, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 221.6 | 121.5 | 141.1 | 130.8 | 142.2 | 32.9 | -387.0 | 84.0 | 31.2 | 32.8 | 6.9 | 0.0 |
Tax Paid | -57.4 | -29.0 | -27.6 | -3.5 | -14.7 | -7.6 | -20.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Adjustment | 27.0 | 19.6 | 9.3 | 11.6 | 29.1 | 39.0 | 392.9 | 48.3 | 33.7 | 1.3 | 2.0 | 0.0 |
Changes In Working Capital | 221.6 | 121.5 | 141.1 | 130.8 | 142.2 | 32.9 | -387.0 | 84.0 | 31.2 | 32.8 | 6.9 | 0.0 |
Cash Flow after changes in Working Capital | 214.6 | 67.3 | 172.4 | 90.1 | 141.7 | 42.6 | -28.1 | 115.3 | -28.1 | 24.5 | -1.4 | 0.0 |
Cash Flow from Operating Activities | 157.2 | 38.2 | 144.9 | 86.6 | 127.0 | 35.0 | -48.3 | 115.3 | -28.1 | 24.5 | -1.4 | 0.0 |
Cash Flow from Investing Activities | -56.5 | -52.4 | -43.9 | -136.2 | -7.1 | -2.8 | -3.1 | -203.4 | -51.2 | -53.4 | -14.4 | 0.0 |
Cash Flow from Financing Activities | -68.8 | -19.7 | -14.3 | -12.6 | -134.6 | -28.8 | 53.0 | 52.2 | 107.5 | 32.5 | 16.4 | 0.0 |
Net Cash Inflow / Outflow | 32.0 | -33.8 | 86.7 | -62.2 | -14.8 | 3.3 | 1.6 | -35.9 | 28.2 | 3.7 | 0.6 | 0.0 |
Opening Cash & Cash Equivalents | -22.0 | 9.5 | -74.5 | -0.6 | 2.0 | 0.7 | 1.8 | 33.9 | 5.7 | 2.0 | 1.4 | 0.0 |
Closing Cash & Cash Equivalent | 13.4 | -22.0 | 9.5 | -74.5 | -11.7 | 2.0 | 0.7 | 4.0 | 33.9 | 5.7 | 2.0 | 0.0 |
The Industry PFCF Ratio stands at 31.50, vs the PFCF Ratio of 7.34, which results in a Negative aspect.
The Industry PCF RATIO stands at 24.67, vs the PCF RATIO of 6.26, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 4,680.2 | 4,518.3 | 4,395.3 | 4,249.7 | 4,279.9 | 4,166.5 | 3,779.7 | 3,440.8 | 3,254.6 | 3,079.0 | 2,643.6 | 2,330.2 | 2,239.0 | 2,212.0 | 2,184.0 | 2,330.4 |
Total Income | 4,753.3 | 4,571.5 | 4,450.4 | 4,286.4 | 4,357.5 | 4,197.0 | 3,790.8 | 3,493.7 | 3,267.9 | 3,124.4 | 2,685.1 | 2,353.3 | 2,282.7 | 2,241.3 | 2,254.8 | 2,413.8 |
Total Expenditure | 4,034.5 | 3,870.1 | 3,782.8 | 3,566.0 | 3,639.7 | 3,567.7 | 3,334.2 | 3,114.7 | 2,850.3 | 2,778.6 | 2,400.5 | 2,007.7 | 1,919.6 | 1,769.9 | 1,845.7 | 2,031.9 |
PBIDT (Excl OI) | 645.7 | 648.3 | 612.5 | 683.7 | 640.2 | 598.9 | 445.5 | 326.2 | 404.4 | 300.4 | 243.1 | 322.5 | 319.4 | 442.1 | 338.4 | 298.5 |
Other Income | 73.1 | 53.2 | 55.2 | 36.7 | 77.6 | 30.5 | 11.1 | 52.9 | 13.3 | 45.5 | 41.5 | 23.1 | 43.7 | 29.3 | 70.7 | 83.4 |
Operating Profit | 718.8 | 701.4 | 667.6 | 720.4 | 717.8 | 629.3 | 456.6 | 379.0 | 417.7 | 345.9 | 284.7 | 345.6 | 363.2 | 471.4 | 409.1 | 381.9 |
Interest | 9.2 | 11.4 | 10.5 | 11.2 | 11.5 | 10.6 | 10.7 | 15.0 | 13.4 | 11.6 | 10.5 | 11.8 | 12.3 | 15.7 | 16.2 | 20.0 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 709.6 | 690.1 | 657.2 | 709.2 | 706.3 | 618.7 | 446.0 | 364.1 | 404.3 | 334.3 | 274.1 | 333.8 | 350.9 | 455.7 | 392.9 | 361.9 |
Depreciation | 78.5 | 75.9 | 71.1 | 70.2 | 71.5 | 68.9 | 53.3 | 49.1 | 42.7 | 36.5 | 33.2 | 31.0 | 31.2 | 30.3 | 30.2 | 29.8 |
Profit Before Tax | 631.2 | 614.2 | 586.1 | 639.0 | 634.8 | 549.8 | 392.7 | 315.0 | 361.6 | 297.7 | 240.9 | 302.8 | 319.7 | 425.4 | 362.7 | 332.1 |
Tax | 150.8 | 155.6 | 140.5 | 146.6 | 169.3 | 134.6 | 82.7 | 88.9 | 96.0 | 76.1 | 36.7 | 56.1 | 56.2 | 173.2 | 71.6 | 39.6 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 480.4 | 458.6 | 445.6 | 492.4 | 465.5 | 415.3 | 310.0 | 226.0 | 265.5 | 221.6 | 204.2 | 246.7 | 263.5 | 252.2 | 291.1 | 292.6 |
Net Profit | 480.4 | 458.6 | 445.6 | 492.4 | 465.5 | 415.3 | 310.0 | 226.0 | 265.5 | 221.6 | 204.2 | 246.7 | 263.5 | 252.2 | 291.1 | 292.6 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 273.0 | 273.0 | 272.7 | 272.6 | 272.6 | 272.6 | 272.3 | 280.5 | 280.5 | 280.5 | 280.2 | 280.2 | 279.0 | 278.6 | 278.5 | 278.5 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 17.6 | 16.8 | 16.3 | 18.1 | 17.1 | 15.2 | 11.1 | 8.1 | 9.5 | 7.9 | 7.3 | 8.8 | 9.5 | 9.1 | 10.5 | 10.5 |
Operating Profit Margin | 15.4 | 15.5 | 15.2 | 17.0 | 16.8 | 15.1 | 12.1 | 11.0 | 12.8 | 11.2 | 10.8 | 14.8 | 16.2 | 21.3 | 18.7 | 16.4 |
Net Profit Margin | 10.3 | 10.1 | 10.1 | 11.6 | 10.9 | 10.0 | 8.2 | 6.6 | 8.2 | 7.2 | 7.7 | 10.6 | 11.8 | 11.4 | 13.3 | 12.6 |
The Industry Mcap Growth stands at 670368.94, vs the Mcap Growth of -40.02, which results in a Negative aspect.
The Industry Net Sales Growth stands at 15.57, vs the Net Sales Growth of 6.85, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,305.85 | 1,327.93 | 1,276.85 |
R3 | 1,297.23 | 1,295.85 | 1,271.35 |
R2 | 1,288.62 | 1,287.93 | 1,269.52 |
R1 | 1,277.23 | 1,275.85 | 1,267.68 |
Pivot | 1,268.62 | 1,267.93 | 1,268.62 |
S1 | 1,257.23 | 1,255.85 | 1,264.02 |
S2 | 1,248.62 | 1,247.93 | 1,262.18 |
S3 | 1,237.23 | 1,235.85 | 1,260.35 |
S4 | 1,225.85 | 1,207.93 | 1,254.85 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
80.40
Bearish
RSI
73.96
Bearish
ROC
19.41
Bullish
UltimateOscillator
65.99
Neutral
Williams Indicator
-9.88
Bearish
CCI Indicator
106.38
Bearish
MACD
-2,095.21
Bearish
Stochastic Indicator
88.22
Neutral
ATR
49.45
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
16-11-2023 | 3.00 | 30 | Interim |
09-06-2023 | 3.00 | 30 | Final |
09-06-2023 | 2.50 | 25 | Special |
16-06-2022 | 2.50 | 25 | Final |
27-05-2021 | 2.50 | 25 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
06-02-2024 | Quarterly Results |
20-01-2024 | Inter alia, to consider and approve the appointment of KMP in place of vacant position caused on 03.11.2023 by resignation of Managing Director of the Company in accordance with the provisions of Regulation 26A of SEBI(LODR) Regulations, 2015 and Section 203 of Companies Act 2013 |
03-11-2023 | Interim Dividend & Quarterly Results |
21-09-2023 | Inter alia, to fix date of EGM under section 100 of Companies Act 2013 |
23-08-2023 | Amalgamation |
28-07-2023 | Quarterly Results |
28-07-2023 | Quarterly Results |
30-06-2023 | Inter alia, to consider and approve :- 1. To take note of the proceedings of Annual General meeting held on 16th June 2023. 2. Re-designate Mr. C.V.Subramanyam, Chairman & Managing Director as Non-executive chairman of the Company. 3. Authorisation to any official to discharge the responsibilities & sign necessary documents to conduct business of the Company. 4. Any other matter with the permission of chair. |
02-05-2023 | Audited Results & Final Dividend & A.G.M. |
02-05-2023 | Inter alia, approved:- 1. Notice of 25th Annual General Meeting to be held on Friday, 16th June, 2023. 2. Directors report for the financial year 2022-23. 4. Recommended a final dividend of Rs.3.00 per equity share and special dividend of Rs.2.50/- per equity share of Rs.10/- each subject to approval of the shareholders of the Company. 5. Secretarial Audit report for the financial year 2022-23. 6. Noted that the Nomination & Remuneration Committee in its meeting held on 2nd May, 2023 has approved the allotment of 15,000 equity shares under ?Cigniti ESOP 2015?. |
31-03-2023 | Inter alia, to consider and approve the appointment of Mr. Srinivas Kandula as Whole-time Director of the Company. |
27-03-2023 | Inter alia, to consider and approve Appointment of Mr. Srinivas Rao Kandula as Director of the Company |
31-01-2023 | Quarterly Results |
24-11-2022 | Inter alia, to consider and approve - Incorporation of an Overseas Subsidiary Company in Costa Rica, Central America |
20-10-2022 | Quarterly Results |
29-07-2022 | Quarterly Results |
29-06-2022 | Buy Back of Shares |
18-05-2022 | Buy Back of Shares Inter alia, to consider and approve the following: 1. Proposal for buy back of fully paid-up equity shares of the Company. 2. Any other matter with the permission of chair. |
04-05-2022 | Audited Results & Final Dividend & Employees Stock Option Plan & Inter alia, to consider and approve the following: 1. Audited financial results on consolidated and standalone basis for the quarter & year ended 31.03.2022. 2. Audit report for the year ended 31.03.2022. 3. Recommend a final dividend for the year ended 31.03.2022. 4. Re-appointment of Independent Directors for further period of 5 yrs subject to approval of members. 5. Formation of ESOP trust and secondary acquisition of shares for implementing the ESOP Scheme subject to approval of members. 6. ?Cigniti Employee Stock Option Plan-2022? (ESOP-2022) for employees of the Company and its subsidiaries subject to approval of members. 7. Possible acquisition of Digital Services Company. 8. Any other matter with the permission of chair |
28-01-2022 | Quarterly Results |
21-10-2021 | Quarterly Results |
23-07-2021 | Quarterly Results |
07-06-2021 | Inter alia, to consider and approve : 1. Review the operations of the Company as on date 2. Approve the changes in employment terms of Mr. Ganesh Ramamoorthy, Chief Revenue officer of Cigniti Technologies Inc; USA a wholly owned subsidiary Company on the recommendation of Nomination & Remuneration Committee. 3. Take note the issue of 25000 ESOPs by Nomination & Remuneration Committee to Mr. Ganesh Ramamoorthy, Chief Revenue officer of Cigniti Technologies Inc; USA a wholly owned subsidiary Company under Cigniti ESOP Scheme 2014(I). 4. Any other matter with the permission of chair. |
29-04-2021 | Final Dividend & Audited Results |